Login / Signup

Drug survival of secukinumab for moderate-to-severe plaque psoriasis.

Erica B LeeK A ReynoldsD J PithadiaJ J Wu
Published in: The British journal of dermatology (2018)
Keyphrases
  • ankylosing spondylitis
  • drug induced
  • coronary artery disease
  • high intensity
  • early onset
  • free survival
  • adverse drug
  • atopic dermatitis
  • disease activity
  • electronic health record